Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:680-685
Published online before print February 21, 2002, doi: 10.1161/01.ATV.0000013287.08141.74
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/4/680    most recent
01.ATV.0000013287.08141.74v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broeders, M. A.W.
Right arrow Articles by oude Egbrink, M. G.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broeders, M. A.W.
Right arrow Articles by oude Egbrink, M. G.A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
Medline Plus Health Information
*Cholesterol
*Diets
Related Collections
Right arrow Risk Factors
Right arrow Thrombosis risk factors
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:680.)
© 2002 American Heart Association, Inc.


Thrombosis

Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules

Complete Reversal by L-Arginine

Martijn A.W. Broeders; Geert Jan Tangelder; Dick W. Slaaf; Robert S. Reneman; Mirjam G.A. oude Egbrink

From the Departments of Physiology (M.A.W.B., G.J.T., R.S.R., M.G.A.o.E.) and Biophysics (D.W.S.), CARIM, Maastricht University, Maastricht, the Netherlands. Dr Broeders is now at the Department of Internal Medicine, Rijnland Hospital, Leiderdorp, the Netherlands, and Dr Tangelder is now at the Laboratory for Physiology, ICAR-VU, Vrije Universiteit Medical Center, Amsterdam, the Netherlands.

Correspondence to M.G.A. oude Egbrink, PhD, Department of Physiology, Maastricht University, PO Box 616, 6200 MD Maastricht, Netherlands. E-mail M.oudeEgbrink{at}fys.unimaas.nl

We investigated in vivo the effect of cholesterol diet–induced hypercholesterolemia (HC) on thromboembolism in nonatherosclerotic rabbit mesenteric arterioles and venules (diameter 21 to 45 µm). After mechanical vessel wall injury, the ensuing thromboembolic reaction was studied by intravital videomicroscopy. A dramatic prolongation of embolization duration (median >600 seconds) was observed in the arterioles of the HC group compared with the arterioles of a normal chow–fed (NC) control group (142 seconds, P<0.0001); concomitantly, relative thrombus height increased (thrombus height/vessel diameter was 68% for the HC group and 58% for the NC group; P<0.05). By contrast, in venules, cholesterol did not affect embolization duration (42 seconds for HC group, 34 seconds for NC group) and thrombus height (66% for HC group, 64% for NC group). Furthermore, the role of endothelial NO synthesis was studied. In arterioles, stimulation of endogenous NO synthesis through mesenteric superfusion of L-arginine (1 mmol/L) completely reversed cholesterol-enhanced embolization (152 seconds) but did not influence thrombus height (63%). L-Arginine had no effect in venules of the HC group (51 seconds) and nor in the arterioles and venules of the NC group (177 seconds for arterioles, 43 seconds for venules). This study indicates that hypercholesterolemia selectively enhances thrombus formation and embolization in arterioles but not in venules and that stimulation of endogenous NO production antagonizes this enhancement of arteriolar thromboembolism.


Key Words: vessel wall injury • in vivo thromboembolism • nitric oxide • cholesterol




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Haraguchi, K. Okada, Y. Tabata, Y. Maniwa, Y. Hayashi, and Y. Okita
Controlled Release of Basic Fibroblast Growth Factor From Gelatin Hydrogel Sheet Improves Structural and Physiological Properties of Vein Graft in Rat
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 548 - 555.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. van Gestel, J. W.M. Heemskerk, D. W. Slaaf, V. V.T. Heijnen, R. S. Reneman, and M. G.A. oude Egbrink
In Vivo Blockade of Platelet ADP Receptor P2Y12 Reduces Embolus and Thrombus Formation but Not Thrombus Stability
Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 518 - 523.
[Abstract] [Full Text] [PDF]